Information Provided By:
Fly News Breaks for October 9, 2015
ZURVY, WY, WFC, RPD, PCH, PH, PRXL, OTIC, NHYDY, NYRT, FEYE, FBR, LLY, CHUY, CSLT, CSX, MT, NLY, ALB, ABB
Oct 9, 2015 | 09:59 EDT
Today's noteworthy upgrades include: ABB (ABB) upgraded to Hold from Underperform at Jefferies... Albemarle (ALB) upgraded to Conviction Buy from Buy at Goldman... Annaly Capital (NLY) upgraded to Market Perform from Underperform at FBR Capital... ArcelorMittal (MT) upgraded to Overweight from Neutral at JPMorgan... CSX (CSX) upgraded to Buy from Neutral at Buckingham... Castlight Health (CSLT) upgraded to Overweight from Equal-Weight at First Analysis... Chuy's (CHUY) upgraded to Outperform from Neutral at Wedbush... Eli Lilly (LLY) upgraded to Outperform from Neutral at Credit Suisse... Fibria Celulose (FBR) upgraded to Buy from Neutral at Citi... FireEye (FEYE) upgraded to Hold from Sell at Gabelli... New York REIT (NYRT) upgraded to Outperform from Market Perform at JMP Securities... Norsk Hydro (NHYDY) upgraded to Buy from Neutral at Goldman... Otonomy (OTIC) upgraded to Buy from Neutral at BofA/Merrill... PAREXEL (PRXL) upgraded to Outperform from Neutral at Baird... Parker-Hannifin (PH) upgraded to Neutral from Underweight at JPMorgan... Potlatch (PCH) upgraded to Neutral from Sell at UBS... Rapid7 (RPD) upgraded to Overweight from Equal Weight at Barclays... Wells Fargo (WFC) upgraded to Overweight from Neutral at JPMorgan... Weyerhaeuser (WY) upgraded to Neutral from Sell at UBS... Zurich Insurance (ZURVY) upgraded to Buy from Hold at HSBC.
News For ABB;ALB;NLY;MT;CSX;CSLT;CHUY;LLY;FBR;FEYE;NYRT;NHYDY;OTIC;PRXL;PH;PCH;RPD;WFC;WY;ZURVY From the Last 2 Days
LLY
Mar 18, 2024 | 10:41 EDT
Oprah Winfrey is hosting a television special on Monday to discuss how WeightWatchers (WW) and weight loss drugs helped her with weight and obesity, CNN's Lisa Respers France reports. "An Oprah Special: Shame, Blame and the Weight Loss Revolution" will be a sit-down conversation around the "radical impact of prescription weight loss medications," according to promotional material for the special. Winfrey, who recently exited the board of WW, will moderate the conversation in front of a live audience with medical experts to explore "prevailing questions and concerns surrounding the impact on our health care, economy, lifestyle and culture," according to a press release for the event. "It is a very personal topic for me and for the hundreds of millions of people impacted around the globe who have for years struggled with weight and obesity," Winfrey said. Weight loss drug options include Eli Lilly's (LLY) Mounjaro and Novo Nordisk's (NVO) Ozempic. Reference Link